about
Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor.Methylation of the calcium channel regulatory subunit α2δ-3 (CACNA2D3) predicts site-specific relapse in oestrogen receptor-positive primary breast carcinomasCorrelation of TP53 and MDM2 genotypes and clinical outcome in platinum-treated head and neck cancer patients with more than 10 years' follow-up.Gene dosage of the spermidine/spermine N(1)-acetyltransferase ( SSAT) gene with putrescine accumulation in a patient with a Xp21.1p22.12 duplication and keratosis follicularis spinulosa decalvans (KFSD)The combination of docetaxel and the somatostatin analogue lanreotide on androgen-independent docetaxel-resistant prostate cancer: experimental data.Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.Loss of reelin expression in breast cancer is epigenetically controlled and associated with poor prognosisRegulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review).High frequency of complex TP53 mutations in CNS metastases from breast cancer.Identification of Endoglin as an epigenetically regulated tumour-suppressor gene in lung cancerSite-specific CpG methylation in the CCAAT/enhancer binding protein delta (CEBPδ) CpG island in breast cancer is associated with metastatic relapseEpigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma.Genetic and epigenetic factors affect RET gene expression in breast cancer cell lines and influence survival in patients.Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinomaTargeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies.The relevance of ADCC for EGFR targeting: A review of the literature and a clinically-applicable method of assessment in patients.Schedule-dependent interaction between temsirolimus and cetuximab in head and neck cancer: a preclinical study.The effect of paclitaxel and nab-paclitaxel in combination with anti-angiogenic therapy in breast cancer cell lines.Treatment effect of buparlisib, cetuximab and irradiation in wild-type or PI3KCA-mutated head and neck cancer cell lines.MicroRNAs role as potential biomarkers and key regulators in melanoma.Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging.Differential molecular mechanism of docetaxel-octreotide combined treatment according to the docetaxel-resistance status in PC3 prostate cancer cells.Combination of bevacizumab and irradiation on uveal melanoma: an in vitro and in vivo preclinical study.Combination of docetaxel and vandetanib in docetaxel-sensitive or resistant PC3 cell line.Impact of erythropoietin on the effects of irradiation under hypoxia.Prognostic Value of Different Allelic Polymorphism of Aldosterone Synthase Receptor in a Congestive Heart Failure European Continental Ancestry Population.E1 detection as prognosticator in human papillomavirus-positive head and neck cancers.p16 cutoff in head and neck squamous cell carcinoma: correlation between tumor and patient characteristics and outcome.Head and neck cancer: improving outcomes with a multidisciplinary approach.Inhibition of the Polyamine Synthesis Pathway Is Synthetically Lethal with Loss of Argininosuccinate Synthase 1.Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapyRole of the renin-angiotensin-aldosterone system and the glutathione S-transferase Mu, Pi and Theta gene polymorphisms in cardiotoxicity after anthracycline chemotherapy for breast carcinoma.Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.Successful treatment of Acremonium fungemia with voriconazole.Impact of age on acute toxicity induced by bio- or chemo-radiotherapy in patients with head and neck cancer.MDM2 309 polymorphism predicts outcome in platinum-treated locally advanced head and neck cancer.Refinement of the SPG9 locus on chromosome 10q23.3-24.2 and exclusion of candidate genesMolecular and cytogenetic analysis of the fragile X syndrome in a series of 453 mentally retarded subjects: a study of 87 familiesSupra-additive antitumor effect of sunitinib malate (SU11248, Sutent) combined with docetaxel. A new therapeutic perspective in hormone refractory prostate cancerCisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study
P50
Q24310015-DADFAA14-4F0F-4DD6-8E59-DDB4256449DDQ24632584-7037A14E-D075-4159-B61C-558381E3AE4FQ27853350-0575DB9A-0422-4CCB-B69A-4A718C37853CQ28221318-557D8517-6BEE-4DB5-87C1-E58DDD42F1B6Q31156220-3CA05FF8-7B63-44A1-A45F-B64D4F9E6219Q34028615-3955F92B-4137-4728-879D-C660BC22C0C8Q34254431-9C6B6170-EE1E-4B4F-A00D-9A0065D324BAQ34478948-FA9F7350-FBB4-43B1-8C87-AB321AC02DC5Q35682017-C8D8CA87-D538-4C9E-9FBB-488F9AFD4630Q36081416-050D0F32-1EB1-4FB7-87FC-750174C77759Q36166817-2D571CB3-05C4-4219-8452-703AE80E6418Q36586507-9336ADB1-AFCA-4208-B722-668F95A34D97Q37295706-407DE003-E47B-41D7-B72F-A1861D04FAA4Q37536848-055CBB18-5DAA-478F-A14E-A44CA22844CAQ37705932-73BEE268-E786-44BF-8657-FA5C8A59A529Q38394937-7E89EE7F-CD49-4A80-9AC3-F5E3A4F80660Q38785943-B5BF2EC5-C6CD-48A3-A8A5-EC6FF64C2D52Q38878437-72D9B593-0B84-40EF-A10A-AD1183072250Q38918345-A9D2B9AD-5405-4EA3-A85A-FD31C6DC313AQ38937088-4B99836D-6427-4364-A335-0071C2122262Q39052828-2B0D2AED-6C30-4C0B-9491-1CA26542C0F8Q39276085-4C6CD904-6128-4529-B600-0D0468950874Q39328198-CD53235D-9782-47BA-A2D7-6F261D506FACQ39499854-893BF96E-2B97-40F2-A704-3573ED4813CFQ39842379-1B494439-3966-4000-BB5C-225164978633Q40155786-93FD443A-6FBE-485E-891E-56C8C1434104Q40730502-0C8B78F6-4F5E-4730-A6F6-B1BB756B37D3Q40945997-8A0C6872-D91F-461D-B79D-2054E635F2A3Q41522410-005F7575-36BA-4DD2-91F8-A28CF1AF8DBFQ42369564-7B0259B6-0053-41F8-9368-786B4AEF3F1EQ42505702-00151EC7-89F5-4513-BD84-30D4679B2CEDQ43865776-804F405F-6826-4B77-9024-C2FBB47AD062Q44245132-D85EC1FD-995F-43DB-A72B-18E748ACB59FQ44671020-0795EECB-2B7F-4E21-BE82-F24E86DD7314Q47672135-14E57D63-291B-4742-BD68-58263497B161Q54322741-59019F3D-FB07-4103-9739-0301798865CBQ56993064-A2A276A5-BC57-4081-8983-A5A7EB443B6CQ71578921-EE768B56-0021-437D-8DE8-2EEEFD8D2EA4Q80531135-3A675E33-89C8-4ACE-9013-0165B6A4099EQ84973449-1236E0BD-B9F3-413B-BED0-25FB2386F451
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Cristiana Lo Nigro
@ast
Cristiana Lo Nigro
@en
Cristiana Lo Nigro
@es
Cristiana Lo Nigro
@nl
type
label
Cristiana Lo Nigro
@ast
Cristiana Lo Nigro
@en
Cristiana Lo Nigro
@es
Cristiana Lo Nigro
@nl
prefLabel
Cristiana Lo Nigro
@ast
Cristiana Lo Nigro
@en
Cristiana Lo Nigro
@es
Cristiana Lo Nigro
@nl
P106
P1153
6603354605
P31
P496
0000-0002-3615-2431